Briana Deary

Director, Clinical Development Operations at Prime Medicine

Briana Deary has a diverse and extensive work history in the clinical development operations field. Briana is currently serving as the Director of Clinical Development Operations at Prime Medicine, Inc. since April 2023.

Before joining Prime Medicine, Inc., they worked at bluebird bio, where they held various roles over the years. These roles include Associate Director of Clinical Development Operations from May 2022 to March 2023, Senior Clinical Trial Manager from January 2020 to June 2022, Clinical Trial Manager from July 2017 to January 2020, Associate Clinical Trial Manager from January 2016 to July 2017, and Clinical Research Associate (In-house) from August 2014 to December 2015.

Prior to bluebird bio, Briana worked at inVentiv Health Clinical on assignment at Biogen Idec, where they served as a Clinical Trial Coordinator from August 2012 to August 2014. Briana also had a previous role as a Clinical Trial Administrator at i3 on assignment at Biogen Idec from October 2011 to September 2012.

Briana Deary obtained their Bachelor of Science degree in Health Policy and Management, Biology, and Business Studies from Providence College. Briana attended the college from 2007 to 2011.

Location

Cambridge, United States

Links

Previous companies


Org chart

No direct reports

Teams


Offices

This person is not in any offices


Prime Medicine

4 followers

Prime Medicine was founded to bring the promise of gene editing to patients. We use Prime Editing, a next-generation technology that can “search and replace” to restore normal genetic function almost anywhere in the genome. Prime Editing searches to find the precise place in the genome to edit and replaces the segment of faulty DNA with a correct copy of DNA. A single Prime Editor can correct the individual mutations found across patients, meaning Prime Editing can potentially address more than 90 percent of known disease-causing genetic mutations. We envision a world where this technology can cure, halt, and ultimately prevent genetic diseases, providing lifelong benefit to patients. Prime Medicine offers the opportunity to shape the future of gene editing and transform how medicines are used to treat disease. Realizing the promise of Prime Editing requires a talented team with diversity of viewpoints and expertise. We’re building a group of dedicated, scientifically curious individuals who are passionate about helping patients live longer, healthier lives.


Industries

Employees

51-200

Links